8 October 2020 | Type 1 Diabetes can present before the age of 6 months and is characterised by autoimmunity and rapid loss of beta-cells | Johnson, MB; Patel, KA; De Franco, E; et al. |
20 November 2020 | Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a Diabetes Care Editors' Expert Forum | Riddle, MC; Philipson, LH; Rich, SS; et al. |
7 December 2020 | Common maternal and fetal genetic variants show expected polygenic effects on risk of small- or large-for-gestational-age (SGA or LGA), except in the smallest 3% of babies | Beaumont, RN; Kotecha, SJ; Wood, AR; et al. |
13 June 2018 | Permanent neonatal diabetes: combining sulfonylureas with insulin may be an effective treatment. | Misra, S; Vedovato, N; Cliff, E; et al. |
16 January 2013 | Biallelic PDX1 (insulin promoter factor 1) mutations causing neonatal diabetes without exocrine pancreatic insufficiency | De Franco, E; Shaw-Smith, C; Flanagan, SE; et al. |
6 December 2012 | GATA6 mutations cause a broad phenotypic spectrum of diabetes from pancreatic agenesis to adult-onset diabetes without exocrine insufficiency | De Franco, E; Shaw-Smith, C; Flanagan, SE; et al. |
28 September 2016 | Genome-wide associations for birth weight and correlations with adult disease | Horikoshi, M; Beaumont, RN; Day, FR; et al. |
12 June 2018 | The Common HNF1A Variant I27L is a Modifier of Age at Diabetes Diagnosis in HNF1A-MODY Individuals. | Locke, JM; Saint-Martin, C; Laver, TW; et al. |
18 September 2018 | A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin | Shepherd, MH; Shields, BM; Hudson, M; et al. |
18 April 2019 | A specific CNOT1 mutation results in a novel syndrome of pancreatic agenesis and holoprosencephaly through impaired pancreatic and neurological development | De Franco, E; Watson, RA; Weninger, WJ; et al. |